Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 138

1.

Increased adenosine-to-inosine RNA editing in rheumatoid arthritis.

Vlachogiannis NI, Gatsiou A, Silvestris DA, Stamatelopoulos K, Tektonidou MG, Gallo A, Sfikakis PP, Stellos K.

J Autoimmun. 2019 Sep 4:102329. doi: 10.1016/j.jaut.2019.102329. [Epub ahead of print]

2.

Reactive Vasodilation Predicts Mortality in Primary Systemic Light-Chain Amyloidosis.

Stamatelopoulos K, Georgiopoulos G, Athanasouli F, Nikolaou PE, Lykka M, Roussou M, Gavriatopoulou M, Laina A, Trakada G, Charakida M, Delialis D, Petropoulos I, Pamboukas C, Manios E, Karakitsou M, Papamichael C, Gatsiou A, Lambrinoudaki I, Terpos E, Stellos K, Andreadou I, Dimopoulos MA, Kastritis E.

Circ Res. 2019 Sep 27;125(8):744-758. doi: 10.1161/CIRCRESAHA.119.314862. Epub 2019 Aug 12.

3.

The effect of treatment response on endothelial function and arterial stiffness in depression. A prospective study.

Kokras N, Papadopoulou E, Georgiopoulos G, Dalla C, Petropoulos I, Kontogiannis C, Laina A, Bampatsias D, Stellos K, Kouzoupis AV, Stamatelopoulos K.

J Affect Disord. 2019 Jun 1;252:190-200. doi: 10.1016/j.jad.2019.04.024. Epub 2019 Apr 9.

PMID:
30986734
4.

RNA epigenetics and cardiovascular diseases.

Dorn LE, Tual-Chalot S, Stellos K, Accornero F.

J Mol Cell Cardiol. 2019 Apr;129:272-280. doi: 10.1016/j.yjmcc.2019.03.010. Epub 2019 Mar 14.

PMID:
30880252
5.

Scientists on the Spot: The future of genome editing in cardiovascular medicine.

Stellos K, Musunuru K.

Cardiovasc Res. 2019 Feb 1;115(2):e20-e21. doi: 10.1093/cvr/cvy302. No abstract available.

PMID:
30668681
6.

Challenges and advances of CRISPR-Cas9 genome editing in therapeutics.

Stellos K, Musunuru K.

Cardiovasc Res. 2019 Feb 1;115(2):e12-e14. doi: 10.1093/cvr/cvy300. No abstract available.

PMID:
30668679
7.

Exercise, telomerase activity, and cardiovascular disease prevention.

Stellos K, Spyridopoulos I.

Eur Heart J. 2019 Jan 1;40(1):47-49. doi: 10.1093/eurheartj/ehy707. No abstract available.

PMID:
30496530
8.

Abdominal Fat Tissue Echogenicity: A Marker of Morbid Obesity.

Georgiopoulos G, Kontogiannis C, Stakos D, Bakogiannis C, Koliviras A, Kyrkou A, Karapanou L, Benekos K, Augoulea A, Armeni E, Laina A, Stellos K, Lambrinoudaki I, Stamatelopoulos K.

J Clin Endocrinol Metab. 2019 Feb 1;104(2):301-311. doi: 10.1210/jc.2018-01301.

PMID:
30358874
9.

Dawn of Epitranscriptomic Medicine.

Gatsiou A, Stellos K.

Circ Genom Precis Med. 2018 Sep;11(9):e001927. doi: 10.1161/CIRCGEN.118.001927. Review.

PMID:
30354331
10.

Amyloid-Beta (1-40) Peptide and Subclinical Cardiovascular Disease.

Stamatelopoulos K, Pol CJ, Ayers C, Georgiopoulos G, Gatsiou A, Brilakis ES, Khera A, Drosatos K, de Lemos JA, Stellos K.

J Am Coll Cardiol. 2018 Aug 28;72(9):1060-1061. doi: 10.1016/j.jacc.2018.06.027. No abstract available.

11.

RNA Therapeutics in Cardiovascular Precision Medicine.

Laina A, Gatsiou A, Georgiopoulos G, Stamatelopoulos K, Stellos K.

Front Physiol. 2018 Jul 25;9:953. doi: 10.3389/fphys.2018.00953. eCollection 2018. Review.

12.

Influence of aflibercept on platelet activation profile.

Sobolewska B, Golenko J, Poeschel S, Grimmel C, Gatsiou A, Sopova K, Biedermann T, Schenke-Layland K, Stellos K, Ziemssen F.

Exp Eye Res. 2018 Oct;175:166-172. doi: 10.1016/j.exer.2018.06.009. Epub 2018 Jun 15.

PMID:
29908884
13.

Low Birth Weight: A Novel Cardiovascular Risk Factor?

Laina A, Stellos K.

Circ Genom Precis Med. 2018 Jun;11(6):e002163. doi: 10.1161/CIRCGEN.118.002163. No abstract available.

PMID:
29875126
14.

Amyloid-β (1-40) and Mortality in Patients With Non-ST-Segment Elevation Acute Coronary Syndrome: A Cohort Study.

Stamatelopoulos K, Mueller-Hennessen M, Georgiopoulos G, Sachse M, Boeddinghaus J, Sopova K, Gatsiou A, Amrhein C, Biener M, Vafaie M, Athanasouli F, Stakos D, Pateras K, Twerenbold R, Badertscher P, Nestelberger T, Dimmeler S, Katus HA, Zeiher AM, Mueller C, Giannitsis E, Stellos K.

Ann Intern Med. 2018 Jun 19;168(12):855-865. doi: 10.7326/M17-1540. Epub 2018 May 22.

PMID:
29799975
15.

Circulating progenitor cells and their interaction with platelets in patients with an acute coronary syndrome.

Tatsidou PT, Chantzichristos VG, Tsoumani ME, Sidiropoulou S, Ntalas IV, Goudevenos JA, Stellos K, Tselepis AD.

Platelets. 2019;30(3):314-321. doi: 10.1080/09537104.2018.1430355. Epub 2018 Feb 16.

PMID:
29451832
16.

Platelet-derived chemokines in inflammation and atherosclerosis.

Bakogiannis C, Sachse M, Stamatelopoulos K, Stellos K.

Cytokine. 2019 Oct;122:154157. doi: 10.1016/j.cyto.2017.09.013. Epub 2017 Dec 1.

PMID:
29198385
17.

Comparative Anti-Platelet Profiling Reveals a Potent Anti-Aggregatory Effect of CD34+ Progenitor Cell-Derived Late-Outgrowth Endothelial Cells in vitro.

Chantzichristos VG, Gkrozou F, Stellos K, Paschopoulos ME, Tselepis AD.

J Vasc Res. 2018;55(1):13-25. doi: 10.1159/000481779. Epub 2017 Dec 2.

PMID:
29197873
18.

RNA in the spotlight: the dawn of RNA therapeutics in the treatment of human disease.

Stellos K.

Cardiovasc Res. 2017 Oct 1;113(12):e43-e44. doi: 10.1093/cvr/cvx170. No abstract available.

PMID:
28957542
19.

Adenosine-to-Inosine RNA Editing in Health and Disease.

Gatsiou A, Vlachogiannis N, Lunella FF, Sachse M, Stellos K.

Antioxid Redox Signal. 2018 Sep 20;29(9):846-863. doi: 10.1089/ars.2017.7295. Epub 2017 Sep 26. Review.

PMID:
28762759
20.

Circulating Amyloid-Beta (1-40) Predicts Clinical Outcomes in Patients With Heart Failure.

Stamatelopoulos K, Stellos K.

Rev Esp Cardiol (Engl Ed). 2017 Nov;70(11):905-906. doi: 10.1016/j.rec.2017.05.026. Epub 2017 Jun 20. English, Spanish. No abstract available.

PMID:
28645835

Supplemental Content

Loading ...
Support Center